These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Bruns CJ, Liu W, Davis DW, Shaheen RM, McConkey DJ, Wilson MR, Bucana CD, Hicklin DJ, Ellis LM. Cancer; 2000 Aug 01; 89(3):488-99. PubMed ID: 10931447 [Abstract] [Full Text] [Related]
23. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Barleon B, Siemeister G, Martiny-Baron G, Weindel K, Herzog C, Marmé D. Cancer Res; 1997 Dec 01; 57(23):5421-5. PubMed ID: 9393770 [Abstract] [Full Text] [Related]
25. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Ohta Y, Shridhar V, Bright RK, Kalemkerian GP, Du W, Carbone M, Watanabe Y, Pass HI. Br J Cancer; 1999 Sep 01; 81(1):54-61. PubMed ID: 10487612 [Abstract] [Full Text] [Related]
26. Factors influencing tissue concentration of vascular endothelial growth factor in colorectal carcinoma. Ono T, Miki C. Am J Gastroenterol; 2000 Apr 01; 95(4):1062-7. PubMed ID: 10763960 [Abstract] [Full Text] [Related]
27. Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas. Ludwig HC, Feiz-Erfan I, Bockermann V, Behnke-Mursch J, Schallock K, Markakis E. Anticancer Res; 2000 Apr 01; 20(1A):299-304. PubMed ID: 10769671 [Abstract] [Full Text] [Related]
28. [Correlation of neovascularization and vascular endothelial growth factor in human renal cell carcinoma]. Sato K, Kato T. Gan To Kagaku Ryoho; 1997 Feb 01; 24(4):389-94. PubMed ID: 9063473 [Abstract] [Full Text] [Related]
29. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor. Lu D, Jimenez X, Zhang H, Wu Y, Bohlen P, Witte L, Zhu Z. Cancer Res; 2001 Oct 01; 61(19):7002-8. PubMed ID: 11585724 [Abstract] [Full Text] [Related]
36. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Yoshiji H, Gomez DE, Shibuya M, Thorgeirsson UP. Cancer Res; 1996 May 01; 56(9):2013-6. PubMed ID: 8616842 [Abstract] [Full Text] [Related]
37. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Ng IO, Poon RT, Lee JM, Fan ST, Ng M, Tso WK. Am J Clin Pathol; 2001 Dec 01; 116(6):838-45. PubMed ID: 11764072 [Abstract] [Full Text] [Related]
38. Developmental expression of vascular endothelial growth factor (VEGF) receptors and VEGF binding in ovine placenta and fetal membranes. Bogic LV, Brace RA, Cheung CY. Placenta; 2001 Apr 01; 22(4):265-75. PubMed ID: 11286562 [Abstract] [Full Text] [Related]
39. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Couffinhal T, Kearney M, Witzenbichler B, Chen D, Murohara T, Losordo DW, Symes J, Isner JM. Am J Pathol; 1997 May 01; 150(5):1673-85. PubMed ID: 9137092 [Abstract] [Full Text] [Related]
40. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Samaniego F, Markham PD, Gendelman R, Watanabe Y, Kao V, Kowalski K, Sonnabend JA, Pintus A, Gallo RC, Ensoli B. Am J Pathol; 1998 Jun 01; 152(6):1433-43. PubMed ID: 9626048 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]